Disease States

The World's Smallest Heart Pump

The first percutaneous, single vascular access pump designed for right heart support

Play Full Video

Impella RP®

How It Works:

 The Impella RP heart pump delivers blood from the inlet area, which sits in the inferior vena cava, through the cannula to the outlet opening near the tip of the catheter in the pulmonary artery. The pump can be inserted through a standard catheterization procedure via the femoral vein, into the right atrium, across the tricuspid and pulmonic valves, and into the pulmonary artery.


 The Impella RP can be inserted through a standard catheterization procedure through the femoral vein and into the right atrium, to support a patient’s pulmonary circulation and provide hemodynamic stability.

Right Ventricular Dysfunction is Common in Patients with Cardiogenic Shock during Acute Myocardial Infarction

Learn More

In patients experiencing:

  • Right heart failure
  • Decompensation following left ventricular assist device implantation
  • Myocardial infarction
  • Heart transplant
  • Open-heart surgery

The Impella RP®:

  • FDA approved for right heart failure
  • Allows the patient’s heart to rest
  • Recovers the heart’s ability to pump blood

Automated Impella Controller

How It Works:


The Automated Impella Controller is the primary user control interface for the Impella platform featuring a 10-inch high-resolution display. It controls the Impella catheter performance, monitors for alarms, and displays real-time hemodynamic and catheter position information.

The new integrated purge system automatically sets the purge flow to maintain the purge pressure and eliminates the need to actively monitor purge pressures. Step-by-step on-screen procedures allow for quick and simple set-up and purge cassette procedures; featuring automatic priming, detection of connections, and automatic bolus at completion.

The Automated Impella Controller can be powered by AC power or can operate on internal battery power for at least 60 minutes when fully charged.

Indications for Use

The Impella RP® System is indicated for providing temporary right ventricular support for up to 14 days in patients with a body surface area ≥1.5 m2, who develop acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or open-heart surgery.


The Impella RP System is authorized to be used by healthcare providers (HCP) in the hospital setting for providing temporary right ventricular support for up to 14 days in critical care patients with a body surface area ≥1.5 m2, for the treatment of acute right heart failure or decompensation caused by complications related to Coronavirus Disease 2019 (COVID-19), including pulmonary embolism (PE). The Impella RP has been authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of medical devices under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Contraindications and Warnings

The Impella RP System is contraindicated for patients with the following conditions: Disorders of the pulmonary artery wall that would preclude placement or correct positioning of the Impella RP device. Mechanical valves, severe valvular stenosis or valvular regurgitation of the tricuspid or pulmonary valve. Mural thrombus of the right atrium or vena cava. Anatomic conditions precluding insertion of the pump. Presence of a vena cava filter or caval interruption device, unless there is clear access from the femoral vein to the right atrium that is large enough to accommodate a 22 Fr catheter.

Potential Adverse Events

The potential adverse effects (eg, complications) associated with the use of the Impella RP System: Arrhythmia, Atrial fibrillation, Bleeding, Cardiac tamponade, Cardiogenic shock, Death, Device malfunction, Hemolysis, Hepatic failure, Insertion site infection, Perforation, Phlegmasia cerulea dolens (a severe form of deep venous thrombosis), Pulmonary valve insufficiency, Respiratory dysfunction, Sepsis, Thrombocytopenia, Thrombotic vascular (non-central nervous system) complication, Tricuspid valve injury, Vascular injury, Venous thrombosis, Ventricular fibrillation and/or tachycardia.

In addition to the risks above, there are other WARNINGS and PRECAUTIONS associated with Impella RP.

Visit to learn more.